Skip to content

Ken Herrmann, Director at Aktis Oncology, sold AKTS on Jul 20, 2026

Data as of Oct 16

▼ SELL$86.1K3,506 shares at $24.56Ken Herrmann DirectorAKTS Aktis Oncology, Inc.
Watch AKTS
Traded
Jul 20, 2026
Disclosed
Jul 21, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Ken Herrmann, Director at Aktis Oncology, sold AKTS on Jul 20, 2026TRADEDDISCLOSED
AKTSSimilar stocks (XLV — its sector index fund), rebased to AKTS's price on the disclosure day
AKTS since disclosure
−38.9%
after the sale
Similar stocks (XLV) since disclosure
+10.3%
XLV — its sector index fund

Change in closing price from Jul 21, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLKen Herrmann DirectorAKTS Aktis Oncology, Inc.$33.2Kdisclosed Jul 21 · filed 1 day after the trade

See every trade on AKTS →